AAN Prioritizes Federal, State Reforms to Mitigate Prior Authorization Burdens
Neurology practices currently face an average of 40 prior authorization requests every week, a volume that consumes 13 hours of staff time and delays critical treatment for patients with conditions such as multiple sclerosis and migraine.
Key Clinical Takeaways:
- Data from the American Medical Association indicates that 95% of physicians report these administrative hurdles cause delays in necessary medical care.
- More than 1 in 4 physicians report that prior authorization requirements have resulted in serious adverse clinical events for their patients.
- Legislative efforts, including the Improving Seniors’ Timely Access to Care Act and the Safe Step Act, aim to implement guardrails on insurance utilization management policies.
Administrative Burdens Impede Neurologic Care
Getting insurance approval for neuroimaging or prescription drugs has become a major obstacle to clinical efficiency. According to Dr. Bruce Cohen, a pediatric neurologist in Akron, Ohio, and chair of the American Academy of Neurology (AAN) Advocacy Committee, these requirements frequently force physicians to spend time on administrative tasks rather than patient care.
“The burdens of prior authorization are highly significant and harm patient access to care,” Dr. Cohen told Medscape.
Clinical consequences of these delays can be severe. In patients with multiple sclerosis, forced wait times or administrative hurdles can lead to disease exacerbation, resulting in hospitalizations, emergency department visits, or permanent disability. In a survey by the American Medical Association, 79% of physicians said prior authorization processes led patients to abandon treatment entirely because the approval process is too complex.
Legislative Reform Efforts for Medicare and Private Plans
The AAN is currently prioritizing federal and state-level reforms to mitigate these administrative pressures. Matt Kerschner, director of regulatory affairs and policy for the AAN, said that the organization is actively supporting the Improving Seniors’ Timely Access to Care Act. This legislation would establish guardrails for Medicare Advantage plans, requiring more transparency and efficiency in how prior authorization is implemented.
The AAN also supports the Safe Step Act, which seeks to limit step therapy protocols that require patients to fail on less effective medications before accessing those originally prescribed by their physicians. “We know this can lead to irreversible disease progression as well as a number of adverse outcomes,” Kerschner told Medscape.
Integrating Artificial Intelligence with Clinical Guardrails
While insurance companies are increasingly deploying artificial intelligence to automate authorization decisions, neurologists express concern regarding the risk of algorithmic denials. Dr. Cohen suggests that AI could theoretically improve efficiency if utilized to cross-reference medical records with coverage criteria automatically. However, the potential for automated denials remains a high-priority concern for the AAN.
The organization maintains that any use of AI in utilization management must include a human expert in the loop to prevent inappropriate care denials.
“We are going to continue to fight to make sure that there are robust guardrails in place so that insurers cannot inappropriately use AI to inappropriately deny care,” Kerschner told Medscape. The future of these administrative tasks depends on whether policymakers can enforce transparency while balancing the desire for automated, cost-saving workflows.
Clinicians seeking to influence these policy shifts may engage with the AAN Advocacy Action Center or participate in events such as Neurology on the Hill. These efforts remain the primary mechanism for neurologists to communicate the clinical impact of utilization management to federal legislators.
Founded in 1948 by A.B. Baker at the University of Minnesota, the American Academy of Neurology now represents over 44,000 neurologists and neuroscientists. The organization publishes Neurology, its peer-reviewed flagship journal, and operates a health policy office in Washington, D.C., to support its advocacy work.
Since 2003, the Academy has convened Neurology on the Hill, an annual event where neurologists meet with members of Congress to advance policies affecting neurological care. Its annual meeting draws more than 15,000 attendees from the U.S. and abroad.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.